1. Home
  2. CYTK vs ASB Comparison

CYTK vs ASB Comparison

Compare CYTK & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ASB
  • Stock Information
  • Founded
  • CYTK 1997
  • ASB 1861
  • Country
  • CYTK United States
  • ASB United States
  • Employees
  • CYTK N/A
  • ASB N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ASB Major Banks
  • Sector
  • CYTK Health Care
  • ASB Finance
  • Exchange
  • CYTK Nasdaq
  • ASB Nasdaq
  • Market Cap
  • CYTK 4.6B
  • ASB 4.0B
  • IPO Year
  • CYTK 2004
  • ASB N/A
  • Fundamental
  • Price
  • CYTK $35.39
  • ASB $26.98
  • Analyst Decision
  • CYTK Buy
  • ASB Hold
  • Analyst Count
  • CYTK 13
  • ASB 11
  • Target Price
  • CYTK $71.58
  • ASB $27.64
  • AVG Volume (30 Days)
  • CYTK 1.7M
  • ASB 1.3M
  • Earning Date
  • CYTK 08-07-2025
  • ASB 10-23-2025
  • Dividend Yield
  • CYTK N/A
  • ASB 3.41%
  • EPS Growth
  • CYTK N/A
  • ASB N/A
  • EPS
  • CYTK N/A
  • ASB 0.78
  • Revenue
  • CYTK $85,738,000.00
  • ASB $1,035,964,000.00
  • Revenue This Year
  • CYTK $330.96
  • ASB $56.79
  • Revenue Next Year
  • CYTK $73.41
  • ASB $5.69
  • P/E Ratio
  • CYTK N/A
  • ASB $34.39
  • Revenue Growth
  • CYTK 2635.74
  • ASB 3.82
  • 52 Week Low
  • CYTK $29.31
  • ASB $18.32
  • 52 Week High
  • CYTK $59.39
  • ASB $28.18
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 49.60
  • ASB 67.64
  • Support Level
  • CYTK $36.89
  • ASB $25.01
  • Resistance Level
  • CYTK $39.92
  • ASB $27.17
  • Average True Range (ATR)
  • CYTK 1.78
  • ASB 0.55
  • MACD
  • CYTK -0.06
  • ASB 0.22
  • Stochastic Oscillator
  • CYTK 54.96
  • ASB 86.06

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ASB Associated Banc-Corp

Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.

Share on Social Networks: